glucuronic acid has been researched along with glucagon-like peptide 1 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nishimoto, K; Shima, K; Suda, T; Yoshimoto, S | 1 |
Brinker, T; Geigle, P; Harmening, K; Heile, A; Klinge, PM; Miller, MC; Wallrapp, C | 1 |
de Jong, R; den Dekker, WK; Duckers, HJ; Hoefer, I; Houtgraaf, JH; Kazemi, K; Lewis, AL; Monkhorst, K; Pasterkamp, G; Stratford, PW; Tempel, D; van de Kamp, E; Wallrapp, C; Zijlstra, F | 1 |
Geigle, P; Jork, A; Kassem, M; Thoenes, E; Thürmer, F; Wallrapp, C | 1 |
Farrell, KA; Holt, CM; Kassem, M; Lewis, AL; Malik, N; Wallrapp, C; Wright, EJ | 1 |
5 other study(ies) available for glucuronic acid and glucagon-like peptide 1
Article | Year |
---|---|
Relationship between molecular structures of sugars and their ability to stimulate the release of glucagon-like peptide-1 from canine ileal loops.
Topics: 3-O-Methylglucose; Animals; Carbohydrates; Dogs; Female; Galactose; Glucagon-Like Peptide 1; Glucose; Glucuronates; Glucuronic Acid; Ileum; Kinetics; Male; Maltose; Mesenteric Veins; Methylglucosides; Peptides; Structure-Activity Relationship; Sucrose; Sugar Alcohols | 1990 |
Encapsulated native and glucagon-like peptide-1 transfected human mesenchymal stem cells in a transgenic mouse model of Alzheimer's disease.
Topics: Alginates; Alzheimer Disease; Amyloid beta-Peptides; Animals; Biocompatible Materials; Capsules; Cell Line; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Genetic Therapy; Glucagon-Like Peptide 1; Glucuronic Acid; Hexuronic Acids; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Transgenic; Transfection | 2011 |
Feasibility of intracoronary GLP-1 eluting CellBead™ infusion in acute myocardial infarction.
Topics: Acute Disease; Alginates; Animals; Apoptosis; Balloon Occlusion; Cell- and Tissue-Based Therapy; Female; Glucagon-Like Peptide 1; Glucuronic Acid; Hexuronic Acids; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Pilot Projects; Swine | 2013 |
Cell-based delivery of glucagon-like peptide-1 using encapsulated mesenchymal stem cells.
Topics: Alginates; Animals; Cell Line, Tumor; Cells, Immobilized; Drug Carriers; Endothelial Growth Factors; Glucagon-Like Peptide 1; Glucuronic Acid; Hexuronic Acids; Humans; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neurotrophin 3; Recombinant Proteins | 2013 |
Encapsulated glucagon-like peptide-1-producing mesenchymal stem cells have a beneficial effect on failing pig hearts.
Topics: Alginates; Anatomy, Cross-Sectional; Animals; Apoptosis; Cardiotonic Agents; Cell Survival; Disease Models, Animal; Drug Delivery Systems; Echocardiography; Glucagon-Like Peptide 1; Glucuronic Acid; Heart Failure; Hexuronic Acids; Humans; In Situ Nick-End Labeling; Inflammation; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Myofibroblasts; Neovascularization, Pathologic; Recombinant Fusion Proteins; Sus scrofa; Ventricular Function, Left | 2012 |